Aphex

Aphex BioCleanse System Inc Suspends Director Scott Smith

Retrieved on: 
Friday, March 4, 2022
Stock, Annual report, Ownership, Employment, Security (finance), Securities Exchange Act of 1934, U.S. Securities and Exchange Commission, News, Board of directors, Physics, Director, Person, Board, Company, Intellectual property, Association, Environment, Intention, Technology, GLOBE, Management, Aphex

PITTSFORD, NY, March 04, 2022 (GLOBE NEWSWIRE) -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST), a forward-thinking, publicly-traded company, announces the Board of Directors of Aphex BioCleanse Systems, Inc. has voted in the majority to make the previously announced Suspension of Scott C. Smith, a Director, a permanent termination and for cause.

Key Points: 
  • PITTSFORD, NY, March 04, 2022 (GLOBE NEWSWIRE) -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST), a forward-thinking, publicly-traded company, announces the Board of Directors of Aphex BioCleanse Systems, Inc. has voted in the majority to make the previously announced Suspension of Scott C. Smith, a Director, a permanent termination and for cause.
  • Therefore, it is the position of Aphex that Scott C. Smith does not own the key Patents relating to Oil Remediation and open cell technology.
  • Accordingly, the Aphex Board of Directors has determined, effective immediately, to permanently terminate Scott C. Smith from any and all duties as a Board Director as well any further representation of Aphex BioClease Systems, Inc.
  • To find out more about Aphex and their technologies, visit: Aphex BioCleanse Systems, Inc. - Superior Sanitization (aphexus.com).

Aphex BioCleanse Systems Reports 2021 Third Quarter Operational Results

Retrieved on: 
Monday, November 15, 2021
Foam, Securities Exchange Act of 1934, Water, Aphex, Atmosphere of Earth, Bacteria, ASD, Disease, Technology, Method, Founder, Securities Act of 1933, SEAgel, Board, Company, Disclosure, Board of directors, OTC Markets Group, Patent, FDA, Management, Tourism

PITTSFORD, N.Y., Nov. 15, 2021 /PRNewswire/ -- Aphex BioCleanse Systems, Inc.(OTCPK: SNST) ("Aphex" or "the Company"), a cutting-edge cleaning and disinfection company offering zero-footprint environmental remediation products, and known for its highly acclaimed non-toxic and water-based disinfection product line, Hy-IQWater, today announceda filing of its required financial and disclosure reports with the OTC Pink reporting service for the quarter endingSeptember 30, 2021.

Key Points: 
  • PITTSFORD, N.Y., Nov. 15, 2021 /PRNewswire/ -- Aphex BioCleanse Systems, Inc.(OTCPK: SNST) ("Aphex" or "the Company"), a cutting-edge cleaning and disinfection company offering zero-footprint environmental remediation products, and known for its highly acclaimed non-toxic and water-based disinfection product line, Hy-IQWater, today announceda filing of its required financial and disclosure reports with the OTC Pink reporting service for the quarter endingSeptember 30, 2021.
  • Aphex BioCleanse Systems, Inc is the developer of the world's first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology.
  • The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
  • The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Aphex BioCleanse Systems' Chief Sustainability Officer Scott Smith Invited to Speak at Baylor University About Sustainability Without Compromise™

Retrieved on: 
Thursday, November 4, 2021
Nutrient, Securities Act of 1933, Technology, Disease, Environmental science, Baylor, Gulf of Mexico, Smith, Aphex, FDA, Faculty, Atmosphere, BP, SEAgel, Company, Harvard Business School, Baylor University, Skin, Energy Independence and Security Act of 2007, Securities Exchange Act of 1934, Disinfectant, Student, Management

His presentation will take place on Thursday, November 11, 2021, at 3:30 p.m. CT at the Baylor Sciences Building, Room E125.

Key Points: 
  • His presentation will take place on Thursday, November 11, 2021, at 3:30 p.m. CT at the Baylor Sciences Building, Room E125.
  • Co-hosted by Baylor's Departments of Economics, Environmental Science, and Geosciences, Smith will speak with students, faculty, and staff about his 34-year crusade to stop environmental destruction.
  • Aphex BioCleanse Systems, Inc is the developer of the world's first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology.
  • The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Aphex BioCleanse Systems Announces Dismissal of David J. Weaver As CEO, President, and Director

Retrieved on: 
Saturday, September 18, 2021
Securities Act of 1933, Employment, FDA, Board, CEO, Company, Disease, Technology, Aphex, Securities Exchange Act of 1934, Light, Interim, Director, Management

He will no longer have any role, directly or indirectlly, with the company.

Key Points: 
  • He will no longer have any role, directly or indirectlly, with the company.
  • The dismissal was performed in accordance with the employment agreement between David J. Weaver and the Company.
  • Aphex BioCleanse Systems, Inc is the developer of the world's first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology.
  • The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Aphex BioCleanse Systems Issued Patent for Sustainable, Reusable Open-Cell Foams for Disinfection of Air, Water, and Surfaces

Retrieved on: 
Tuesday, September 14, 2021
Foam, FDA, Technology, Intellectual property, Atmosphere of Earth, Securities Exchange Act of 1934, N-95, Company, Bacteria, Securities Act of 1933, Patent, Risk, EPA, Disease, Product life-cycle theory, IP, Severe acute respiratory syndrome coronavirus 2, Aphex, PPE, Light, Public health, Water, SEAgel, USPTO, Method, Legionella, Vaccine

"When I originally filed this in 2017, my vision was to use my extensive background tackling more than 60 real world contamination events and disasters to infuse Open-Cell Foam with a disinfectant/biocide aimed at killing Algae and Legionella -- I never thought this idea could help to protect public health in a global pandemic three years later," said Aphex Chief Sustainability Officer Scott Smith. "I was shocked to learn that single-use paper towels and cotton rags were contributing to the spread of this virus after my daughter, a frontline worker at a nursing home, along with more than 50% of all the frontline workers at her job, were severely infected even after following all PPE protocols and wearing N-95 masks. We found that single-use paper towels, sponges and cotton rags can deactivate disinfectant and leave live, infectious pathogen droplets that can be transmitted to people via infected surfaces. This motivated me to discover the great benefits of BioFoam paired with an EPA-registered disinfectant to kill dangerous pathogens like SARS-CoV-2."

Key Points: 
  • The patent, which is a key addition to the Company's substantial and growing intellectual property (IP) portfolio, is both a composition of matter patent and a methods patent.
  • "We have created a globally-impactful solution that is working to eliminate harmful pathogens and toxins in a way that supports sustainability without compromise.
  • We believe that we can work to do the right thing while providing great value to our customers and shareholders."
  • Aphex BioCleanse Systems, Inc is the developer of the world's first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology.

Aphex BioCleanse Systems Appoints Anthony Fedor as Interim CEO Focused on Scaling and Growth

Retrieved on: 
Friday, August 27, 2021
General manager, Company, Aphex, Securities Exchange Act of 1934, Eastman Business Park, Energy Independence and Security Act of 2007, Interim, Cornell University, Leadership, Board of directors, Kodak, Disease, Senior, Securities Act of 1933, Board, Marketing, CEO, Organization, Sustainability Accounting Standards Board, FDA, Technology, Management

Fedor will continue to perform his duties as Chairman of the Board while holding the title of Interim President and CEO.

Key Points: 
  • Fedor will continue to perform his duties as Chairman of the Board while holding the title of Interim President and CEO.
  • The new leadership direction will allow the Company to bring in an executive with more experience scaling similar organizations.
  • "I believe that my experience as Chairman of the Board, as well as my background as a manufacturing professional, will help me guide Aphex on its path towards success," said the newly appointed Interim CEO Anthony Fedor.
  • Aphex BioCleanse Systems, Inc is the developer of the world's first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology.

Aphex BioCleanse Systems Releases Letter to Shareholders; Celebrates 11th Anniversary

Retrieved on: 
Thursday, July 22, 2021
Public health, Antiseptics, Disinfectants, Hygiene, Health, Dispensers, Hand, Hand sanitizer, Aphex, Hydrogen vehicle, Food and Drug Administration, Ön

The letter is as follows:

Key Points: 
  • The letter is as follows:
    As we head into August, not only are we celebrating making it halfway through an exciting year for Aphex, but we are observing our eleventh anniversary as a company.
  • Now is by far the most exciting time for our business in its history, and we are just getting started.
  • If and when we should garner such approval, it would make Aphex the manufacturer of the only FDA-approved hand sanitizer.
  • Aphex BioCleanse Systems, Inc is the developer of the world's first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology.

Aphex BioCleanse Systems Acquires BioFoam™ Business and Patented Cleaning Technology; Appoints BioFoam™ Founder and Inventor, Scott Smith, as Chief Sustainability Officer

Retrieved on: 
Friday, June 11, 2021
Articles, Hydrogen economy, Hydrogen vehicle, Aphex, Cleaning agent, Chief sustainability officer, Economy

Aphex has also appointed Scott Smith, the inventor of BioFoam, as the Companys Chief Sustainability Officer.

Key Points: 
  • Aphex has also appointed Scott Smith, the inventor of BioFoam, as the Companys Chief Sustainability Officer.
  • The addition of Smith, BioFoam customers, and patented Open-Cell Foam cleaning technology to its existing, high-performance cleaning products, solidifies Aphex as a technology leader in its field.
  • The appointment of Scott Smith as Aphexs Chief Sustainability Officer could not have been announced at a more opportune time.
  • Aphex BioCleanse Systems, Inc is the developer of the world's first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology.

Aphex BioCleanse Systems Announces Significant Purchase Order for Proprietary, Alcohol-Free Hand Sanitizer Product

Retrieved on: 
Tuesday, May 4, 2021
Food and Drug Administration, United States Public Health Service, Aphex

"We look forward to a long-lasting partnership and expanding the footprint of our products through the company\'s extensive distribution channels.

Key Points: 
  • "We look forward to a long-lasting partnership and expanding the footprint of our products through the company\'s extensive distribution channels.
  • "\nThis initial PO is for 13,750gallons of DermAphex product andis intended to service Infinity Manufacturing\'s clients in a variety of industries.
  • "They expressed excitement about the possibilities presented with Aphex\'s products and we are looking forward to bringing that solution to them through this purchase order.
  • Learn more about Aphex at www.aphexus.com .\nThe statements in this document have not been evaluated or approved by the FDA.

Aphex BioCleanse Systems Promotes Manufacturing Leader Anthony Fedor To Chairman Of The Board

Retrieved on: 
Tuesday, April 27, 2021
Kodak, Forward-looking statement, Aphex, Food and Drug Administration, Economy of the United States, Articles, Companies

"\nFedor, in addition to his contributions to Aphex, is a respected manufacturing professional with more than 55 years of experience.

Key Points: 
  • "\nFedor, in addition to his contributions to Aphex, is a respected manufacturing professional with more than 55 years of experience.
  • Holding this and other significant leadership positions at Kodak, as well as teaching manufacturing at Cornell University, gave Fedor the confidence to go out on his own and acquire manufacturing company Rochester Gear, Inc. in 2007.
  • Learn more about Aphex at www.aphexus.com .\nThe statements in this document have not been evaluated or approved by the FDA.
  • The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.\n'